Croda International Receives Buy Rating from Goldman Sachs (CRDA)
Croda International (LON:CRDA)‘s stock had its “buy” rating reaffirmed by investment analysts at Goldman Sachs in a note issued to investors on Monday, American Banking News reports. They currently have a GBX 3,030 ($49.71) price target on the stock. Goldman Sachs’ target price would indicate a potential upside of 24.95% from the company’s current price.
Shares of Croda International (LON:CRDA) traded up 1.34% on Monday, hitting GBX 2425.00. The stock had a trading volume of 363,069 shares. Croda International has a 1-year low of GBX 2205.00 and a 1-year high of GBX 2846.00. The stock’s 50-day moving average is GBX 2412.36 and its 200-day moving average is GBX 2482.. The company’s market cap is £3.276 billion.
Other equities research analysts have also recently issued reports about the stock. Analysts at Canaccord Genuity reiterated a “sell” rating on shares of Croda International in a research note to investors on Wednesday, February 5th. They now have a GBX 2,030 ($33.31) price target on the stock. Separately, analysts at Berenberg Bank reiterated a “buy” rating on shares of Croda International in a research note to investors on Wednesday, February 5th. They now have a GBX 2,850 ($46.76) price target on the stock. Finally, analysts at BNP Paribas reiterated an “outperform” rating on shares of Croda International in a research note to investors on Friday, January 31st. They now have a GBX 3,000 ($49.22) price target on the stock. Two equities research analysts have rated the stock with a sell rating, seven have assigned a hold rating and ten have given a buy rating to the company. The company currently has an average rating of “Hold” and an average target price of GBX 2,635.72 ($43.24).
Croda International Plc is a marketing and technology company that produces and sells speciality chemicals.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.